Outcome Of Non-surgical Therapy Research Articles

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)

BackgroundNon-small cell lung cancer (NSCLC) stage T4N0-1 or single nodal station IIIA-N2 are two stage III sub-groups for which the outcome of non-surgical therapy is not well known. We investigated the results of individualised isotoxic accelerated radiotherapy (INDAR) and chemotherapy in this setting. MethodsAnalysis of NSCLC patients included in 2 prospective trials (NCT00573040 and NCT00572325) stage T4N0-1 or IIIA-N2 with 1 pathologic nodal station, treated with chemo-radiotherapy (CRT) using INDAR with concurrent or sequential platinum-based chemotherapy. Overall survival (OS) was updated and calculated from date of diagnosis (Kaplan–Meier). Toxicity was scored following CTCAEv3.0. To allow comparison with other articles the subgroups were also analysed separately for toxicity, progression free and overall survival. Results83 patients (42 T4N0-1 and 41 IIIA-N2) were identified: the median radiotherapy dose was 65Gy. Thirty-seven percent of patients received sequential CRT and 63% received concurrent CRT. At a median follow-up of 48months the median OS for T4N0-1 patients was 34months with 55% 2-year survival and 25% 5-year survival. For stage IIIA-N2 at a median follow-up of 50months the median OS was 26months with 2- and 5-year survival rates of 53% and 24%, respectively. ConclusionChemo-radiation using INDAR yields promising survival results in patients with single-station stage IIIA-N2 or T4N0-1 NSCLC.

Adjunctive Antibiotics with Nonsurgical Periodontal Therapy Improve the Clinical Outcome of Chronic Periodontitis in Current Smokers

Article Title and Bibliographic Information A systematic review of clinical efficacy of adjunctive antibiotics in the treatment of smokers with periodontitis. Angaji M, Gelskey S, Nogueira-Filho G, Brothwell D. J Periodontol 2010;81(11):1518-28. Reviewer Jasim M. Albandar, DDS, DMD, PhD, Diplomate ABP Purpose/Question Does the use of adjunctive antimicrobials improve the clinical outcome of nonsurgical therapy (scaling and root planing) or surgical therapy in the treatment of chronic periodontitis in smokers? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 2: Limited-quality, patient-oriented evidence Strength of Recommendation Grade Grade B: Inconsistent or limited-quality patient-oriented evidence